Plasma anti Xa-levels in obese patients undergoing bariatric surgery and receiving low molecular weight heparins for thromboprophylaxis.
Completed
- Conditions
- blood clottingvenous thromboembolism1001799810014523
- Registration Number
- NL-OMON37877
- Lead Sponsor
- Slotervaartziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 45
Inclusion Criteria
a. All patients who have undergone bariatric surgery (laparoscopic gastric banding, duodenal switch procedure, sleeve gastrectomy, gastric bypass) recently and who are receiving enoxaparin 40 mg twice daily as noted in the protocols of the hospital
b. Adults> 18 years old
c. Obtained informed consent
Exclusion Criteria
Patients with at least one of the following criteria will be excluded:
a. enoxaparin dosage different from that specified in the protocol (40 mg twice daily)
b. receiving a thrombolytic agent
c. antithrombin III deficiency
d. renal insufficiency (estimated Glomerular Filtration Rate<30 ml/min)
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Anti-Xa peak concentration and correlation with body weight.</p><br>
- Secondary Outcome Measures
Name Time Method <p>nvt</p><br>